Comparison of oral zinc sulfate with systemic meglumine antimoniate in the treatment of cutaneous leishmaniasis

Dermatology Research and Practice

Volumn 2011, Issue , 2011, Pages

  Yazdanpanah, Mohamad Javad ^a   Banihashemi, Mahnaz ^a   Pezeshkpoor, Fakhrozaman ^a   Khajedaluee, Mohammad ^b   Famili, Sororozaman ^a   Tavakoli Rodi, Iman ^b   Yousefzadeh, Hadis ^c  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84875005708     PISSN: None     EISSN: 16876113     Source Type: Journal    
DOI: 10.1155/2011/269515     Document Type: Article

References (19)

1. Oumeish O. Y., Cutaneous leishmaniasis: a historical perspective. Clinics in Dermatology 1999 17 3 249 254 2-s2.0-0032704924 10.1016/S0738-081X(99)00041- 3 (Pubitemid 29497887)
2. Pearson R. D., De Queiroz Sousu A., Jeronimo S. M. B., Mnadell G. L., Bennett J. E., Dolin R., Leishmania species: visceral (kala-azar), cutaneous and mucosal leishmaniasis. Principles and Practice of Infectious Diseases 2000 5 Philadelphia, Pa, USA Churchill Livingstone 2831 2833
3. Bryceson A. D. M., Hay R. J., Champion R. H., Burton J. L., Burns D. A., Breathnach S. M., Parasitic worms and protozoa. Rook Textbook of Dermatology 1998 6 London, UK Blackwell Science 1411 1412
4. Valizadeh M., Dalimi Asl A. H., Fata A., A study on leishmania species causing cutaneous leishmaniasis in mashhad using specific monoclonal antibodies. Modarres Journal of Medical Sciences 2005 7 2 107 113
5. Desjeux P., Human leishmaniases: epidemiology and public health aspects. World Health Statistics Quarterly 1992 45 2-3 267 275 2-s2.0-0026592139
6. Neouimine N. I., Leishmaniasis in the Eastern Mediterranean Region. Eastern Mediterranean Health Journal 1996 2 1 94 101 2-s2.0-0005758146 (Pubitemid 126414312)
7. Najim R. A., Sharquie K. E., Farjou I. B., Zinc sulphate in the treatment of cutaneous leishmaniasis: an in vitro and animal study. Memorias do Instituto Oswaldo Cruz 1998 93 6 831 837 2-s2.0-0032199155 (Pubitemid 128525455)
8. Najim R. A., Sharquie K. E., Al-Zubaidy S. A., Possible mechanisms of action of the compounds injected intralesionally in the treatment of cutaneous leishmaniasis, in addition to their direct effects on the parasites. Annals of Tropical Medicine and Parasitology 2006 100 1 33 38 2-s2.0-31344464344 10.1179/136485906X78472 (Pubitemid 43139630)
9. Minodier P., Parola P., Cutaneous leishmaniasis treatment. Travel Medicine and Infectious Disease 2007 5 3 150 158 2-s2.0-34247178377 10.1016/j.tmaid.2006.09.004 (Pubitemid 46585958)
10. Sharquie K. E., Najim R. A., Farjou I. B., A comparative controlled trial of intralesionally-administered zinc sulphate, hypertonic sodium chloride and pentavalent antimony compound against acute cutaneous leishmaniasis. Clinical and Experimental Dermatology 1997 22 4 169 173 2-s2.0-0030782329 (Pubitemid 27513115)
11. Iraji F., Vali A., Asilian A., Shahtalebi M. A., Momeni A. Z., Comparison of intralesionally injected zinc sulfate with meglumine antimoniate in the treatment of acute cutaneous leishmaniasis. Dermatology 2004 209 1 46 49 2-s2.0-4444251066 10.1159/000078586 (Pubitemid 39179105)
12. Sharquie K. E., Najim R. A., Farjou I. B., Al-Timimi D. J., Oral zinc sulphate in the treatment of acute cutaneous leishmaniasis. Clinical and Experimental Dermatology 2001 26 1 21 26 2-s2.0-0035093566 10.1046/j.1365-2230. 2001.00752.x (Pubitemid 32204839)
13. Al-Mulla Hummadi Y. M., Al-Bashir N. M., Najim R. A., The mechanism behind the antileishmanial effect of zinc sulphate. II. Effects on the enzymes of the parasites. Annals of Tropical Medicine and Parasitology 2005 99 2 131 139 2-s2.0-15344341984 10.1179/136485905X19937 (Pubitemid 40393041)
14. Yazdanpanah M. J., Mostoufi S. K., Soleymani M., Oral zinc sulfate in the treatment of acute cutaneous leishmaniasis. Iranian Red Crescent Medical Journal 2007 9 4 205 208
15. Layegh P., Yazdanpanah M. J., Dadkhah S. M., Mohammadi Vosough E., Comparative study of oral azithromycin and systemic meglumine antimoniate (glucantime) in the treatment of cutaneous leishmaniasis. Iranian Journal of Dermatology 2007 9 38 303 307
16. Famili S., Pezeshkpour F., Sepehr V., Comparison of efficacy of oral fluconazole with intramuscular glucantime in patients with acute cutaneous leishmaniasis. Iranian Journal of Dermatology 2005 8 2 97 100
17. Berenji F., Yaghoobi M., Akhavan A., Hanafi A., Fata A., A study on vectors of cutaneous Leishmaniasis in northern part of Mashhad, Iran. Iranian Journal of Medical Sciences 2006 9 1 1 6
18. Arevalo I., Ward B., Miller R., Meng T., Najar E., Alvarez E., Matlashewski G., Llanos-Cuentas A., Successful treatment of drug-resistant cutaneous leishmaniasis in humans by use of imiquimod, an immunomodulator. Clinical Infectious Diseases 2001 33 11 1847 1851 2-s2.0-0035577828 10.1086/324161 (Pubitemid 33105123)
19. Jen M., Shah K. N., Yan A. C., Wolff K., Goldsmith L. A., Katz S. I., Skin in nutritional, metabolic and heritable disease. Dermatology in General Medicine 2007 7th New York, NY, USA McGraw-Hill 1215